Free Trial
NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

USANA Health Sciences logo
$32.75 +0.04 (+0.12%)
Closing price 07/9/2025 03:56 PM Eastern
Extended Trading
$32.74 -0.01 (-0.03%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About USANA Health Sciences Stock (NYSE:USNA)

Key Stats

Today's Range
$32.22
$32.79
50-Day Range
$28.03
$32.78
52-Week Range
$23.10
$48.85
Volume
89,584 shs
Average Volume
139,809 shs
Market Capitalization
$609.90 million
P/E Ratio
17.99
Dividend Yield
N/A
Price Target
$36.00
Consensus Rating
Hold

Company Overview

USANA Health Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

USNA MarketRank™: 

USANA Health Sciences scored higher than 71% of companies evaluated by MarketBeat, and ranked 181st out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    USANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    USANA Health Sciences has received no research coverage in the past 90 days.

  • Read more about USANA Health Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of USANA Health Sciences is 17.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of USANA Health Sciences is 17.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.05.

  • Price to Earnings Growth Ratio

    USANA Health Sciences has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    USANA Health Sciences has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about USANA Health Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    9.25% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently decreased by 1.90%, indicating that investor sentiment is improving.
  • Dividend Yield

    USANA Health Sciences does not currently pay a dividend.

  • Dividend Growth

    USANA Health Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.25% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently decreased by 1.90%, indicating that investor sentiment is improving.
  • News Sentiment

    USANA Health Sciences has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for USANA Health Sciences this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $360,149.00 in company stock.

  • Percentage Held by Insiders

    Only 0.63% of the stock of USANA Health Sciences is held by insiders.

  • Percentage Held by Institutions

    54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about USANA Health Sciences' insider trading history.
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

USNA Stock News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
USANA Announces the Elevation of Its Opportunity
See More Headlines

USNA Stock Analysis - Frequently Asked Questions

USANA Health Sciences' stock was trading at $35.89 at the start of the year. Since then, USNA shares have decreased by 8.7% and is now trading at $32.75.

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, April, 22nd. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a net margin of 3.98% and a trailing twelve-month return on equity of 8.94%.
Read the conference call transcript
.

Top institutional shareholders of USANA Health Sciences include Harbor Capital Advisors Inc. (0.04%). Insiders that own company stock include Myron W Wentz, Jim Brown, David Mulham Mulham, Kevin Guest, John Turman Fleming, Peggie Pelosi, Frederic J Winssinger, Xia Ding, Walter Noot, Robert A Sinnott, Paul A Jones, Joshua Foukas, Gilbert A Fuller, G Doug Iiekking, Daniel A Macuga and Brent Neidig.
View institutional ownership trends
.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX).

Company Calendar

Last Earnings
4/22/2025
Today
7/09/2025
Next Earnings (Estimated)
7/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Personal Products
Current Symbol
NYSE:USNA
CIK
896264
Employees
1,700
Year Founded
N/A

Price Target and Rating

High Price Target
$36.00
Low Price Target
$36.00
Potential Upside/Downside
+9.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
17.99
Forward P/E Ratio
13.37
P/E Growth
1.03
Net Income
$42.03 million
Pretax Margin
7.53%

Debt

Sales & Book Value

Annual Sales
$854.50 million
Cash Flow
$3.85 per share
Price / Cash Flow
8.51
Book Value
$27.92 per share
Price / Book
1.17

Miscellaneous

Free Float
18,506,000
Market Cap
$609.81 million
Optionable
Optionable
Beta
0.64

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:USNA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners